Evidence map›Paper›PMID 41390439›Full record

ArticleBMC pharmacology & toxicology2025

Mechanistic exploration of bisphenol A in primary Sjögren's syndrome using network toxicology, molecular docking, molecular dynamics simulations and experimental validation.

Zelin Wang, Jinle Zhang, Jingqi Dong, Shufen Liang

Abstract read
In one paragraph

Article in BMC pharmacology & toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zelin WangDepartment of Laboratory, the Second Hospital of Shanxi Medical University, Taiyuan, China.
Jinle ZhangDepartment of Laboratory, the Second Hospital of Shanxi Medical University, Taiyuan, China.
Jingqi DongDepartment of Laboratory, the Second Hospital of Shanxi Medical University, Taiyuan, China.
Shufen LiangDepartment of Laboratory, the Second Hospital of Shanxi Medical University, Taiyuan, China. liangshufen9344@163.com.ORCID 0009-0004-3656-354X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary Sjögren's syndrome (pSS) is a chronic autoimmune disorder marked by exocrine gland impairment and systemic manifestations. Environmental endocrine disruptors, including bisphenol A (BPA), have been associated with immunological dysregulation; however, their involvement in pSS is not well-defined. This study integrated network toxicology, molecular docking, molecular dynamics simulation, and in vitro validation to examine the potential effects of BPA on pSS. Bioinformatics investigation revealed 25 overlapping targets between BPA-associated genes and differentially expressed genes related to pSS, with CASP3, PTGS1, and PTGS2 identified as main possibilities. Molecular docking and molecular dynamics simulations validated robust and stable interactions of BPA with these proteins. Cellular studies with human submandibular gland epithelial cells demonstrated dose-dependent cytotoxicity of BPA, accompanied by substantial overexpression of CASP3, PTGS1, and PTGS2 at 1 µM exposure. The data indicate that BPA enhances apoptosis and inflammatory signaling in salivary gland cells, potentially contributing to pSS progression. This study provides mechanistic insight into how BPA may contribute to autoimmune disease development, highlighting its potential role in pSS.

Indexed as

Benzhydryl CompoundsEndocrine DisruptorsPhenolsSjogren's SyndromeApoptosisBisphenol A CompoundsCaspase 3Cell LineCyclooxygenase 1Cyclooxygenase 2Epithelial CellsHumansMolecular Docking SimulationMolecular Dynamics SimulationBenzhydryl Compoundsbisphenol ABisphenol A CompoundsCaspase 3Cyclooxygenase 1Cyclooxygenase 2Endocrine DisruptorsPhenolsPTGS2 protein, humanBisphenol AMolecular dockingMolecular dynamics simulationsNetwork toxicologyPrimary Sjögren's syndrome

Identifiers

PMID41390439
PMCPMC12822272

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.